Review of Systemic Immunosuppression for Autoimmune Uveitis - Wikidata - awgldk - TriplyDB

Review of Systemic Immunosuppression for Autoimmune Uveitis

Review of Systemic Immunosuppression for Autoimmune Uveitis

http://www.wikidata.org/entity/Q34627012

about

Therapeutic effects of mesenchymal stem cells administered at later phase of recurrent experimental autoimmune uveitis.Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches.Sepsis During Immunosuppression for Sight-threatening Uveitis: The Flip side.Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells.

P2860

Q37359825-2F92778F-F359-4292-B7C2-3620AF7B8EA4 Q39426072-AF3B9053-6664-42C4-A2A3-4FD98D8232EE Q40569975-CDAA5198-4A12-4246-B0A2-8B96F9C6F4C3 Q46602988-DC87E684-AF04-4F5E-8908-5B6F21371B20

P2860

Review of Systemic Immunosuppression for Autoimmune Uveitis

http://www.wikidata.org/entity/Q34627012

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Review of Systemic Immunosuppression for Autoimmune Uveitis

@ast

Review of Systemic Immunosuppression for Autoimmune Uveitis

@en

Review of Systemic Immunosuppression for Autoimmune Uveitis

@nl

type

label

Review of Systemic Immunosuppression for Autoimmune Uveitis

@ast

Review of Systemic Immunosuppression for Autoimmune Uveitis

@en

Review of Systemic Immunosuppression for Autoimmune Uveitis

@nl

prefLabel

Review of Systemic Immunosuppression for Autoimmune Uveitis

@ast

Review of Systemic Immunosuppression for Autoimmune Uveitis

@en

Review of Systemic Immunosuppression for Autoimmune Uveitis

@nl

P1433

Q34627012-2B867193-D059-4D33-AC11-7631F31B5BE9

P1476

Q34627012-046F7F29-65F3-4928-AB04-869DE39E5129

P2093

Q34627012-4205F679-1350-40BD-BC2A-5B000D884209

Q34627012-F38CB084-E242-4D1E-894D-C21DCBBFACE1

P2860

Q34627012-00B1AD91-2349-4A44-A1CF-B2E1DB8CB74F

Q34627012-02DCF8A4-66BD-4793-BA0E-7E452C232AD1

Q34627012-08446DB6-4E8F-4DCD-BC6A-D4A02C1AE968

Q34627012-09C08823-F1F7-4A98-B582-BBB6D34E7D53

Q34627012-0A44C101-2EC3-4755-9643-9DE44A4E7641

Q34627012-0D8A4986-A6BA-4478-9248-AF84BDF11D72

Q34627012-10CC7CB8-BE72-49F5-8595-8F99ADF5848D

Q34627012-136339D8-50B8-45B9-87B1-EA78EC41F1F8

Q34627012-18587171-C9BC-4893-9755-94D9B3568AA8

Q34627012-1942B9C7-C97E-40AC-A783-7A115687AE11

P2888

Q34627012-3402DBE6-9455-4C28-96ED-B42CA1203161

P304

Q34627012-CC20290F-311A-44CC-B4E7-88CD1F4B4C65

P31

Q34627012-4705523C-A4B1-4540-9199-6320FE85445E

P356

Q34627012-BCDC2020-7CA9-4735-BFC9-5CBB5EEE6D45

P433

Q34627012-DED7F8DC-B914-46ED-BEAF-C59C5D37AA3F

P478

Q34627012-BB840F08-298F-4B58-BA63-D1F5A1C9BBB1

P577

Q34627012-59A95D03-022B-474C-9E92-BFB9C8071BDE

P5875

Q34627012-9BE411F9-E5AC-4053-BF83-7E7DBCEDE30B

P6179

Q34627012-FF752AD1-251A-41A0-87F9-F40B49C2E433

P698

Q34627012-2737F551-6AB2-46B8-8A6D-7D7B106FD1E7

P921

Q34627012-4197550A-5023-4079-8646-D9D466A2B871

Q34627012-EC5EE553-990A-4E8C-8A25-CDF5353AF791

P932

Q34627012-A0CA5505-E7D9-4BFF-A4FA-B3F46EE33536

P356

S40123-014-0023-X

P1433

Ophthalmology and therapy

P1476

Review of Systemic Immunosuppression for Autoimmune Uveitis

@en

P2093

C Stephen Foster

http://www.w3.org/2001/XMLSchema#string

Claudia Castiblanco

http://www.w3.org/2001/XMLSchema#string

P2860

Intravenous immunoglobulin therapy for resistant ocular Behçet's disease

Behçet's disease: a new target for anti-tumour necrosis factor treatment

Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature

Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy

Daclizumab for treatment of birdshot chorioretinopathy

Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis.

Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.

Cyclophosphamide for ocular inflammatory diseases

Mycophenolate mofetil for ocular inflammation.

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

P2888

s40123-014-0023-x

P304

17-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40123-014-0023-X

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264941110

http://www.w3.org/2001/XMLSchema#string

P6179

1026811221

http://www.w3.org/2001/XMLSchema#string

P698

25134495

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

4254861

http://www.w3.org/2001/XMLSchema#string